Why the study?
What is the quality of pharmacotherapy in patients with arterial hypertension observed in primary care practice in Russia?
What is the quality of pharmacotherapy in patients with arterial hypertension observed in primary care practice in Russia?
The quality of pharmacotherapy for arterial hypertension in Russian primary care practice in 2007 was poor, with only 6.5% of patients receiving guideline-concordant treatment.
Signals inadequate primary care hypertension management; leaves open whether quality has improved since 2007 and supports updated audits.
Aim. To assess (on the basis of Russian national guidelines on arterial hypertension (HT), 2004) quality of pharmacotherapy measures among hypertensive patients observed in primary care practice. Material and methods. Data on 12 604 patients with HT (7 819 women, 4 785 men, aged 59.5±12.0 years) from 13 regions of Russia observed in primary care units during 2007 were enrolled in the study. Compliance with recommendations on decision making about pharmacotherapy need (risk category assessment) and adequacy were evaluated. Results. 64% of patients with HT had no drug prescriptions in their outpatient card in 2007. 4 880 patients from 12 604 enrolled HT patients (38.7%) had all data necessary for risk assessment. 3920 patients (31% of the whole studied group) had pharmacotherapy indications (high or very high risk). Only 819 HT patients (6.5% of the whole number of enrolled patients) had antihypertensive pharmacotherapy completely corresponding to their clinical status. Conclusion. The quality of pharmacotherapy measures carried out in primary care practice during 2007 did not conform to HT guidelines.
No takes yet. Share an insight, caveat, or question.
Posnenkova et al. (2011) studied this question.